May 20, 2020 / 5:43 PM / 16 days ago

BRIEF-Ascelia Pharma Provides Updated SPARKLE Timelines Due To Covid-19 Impact

May 20 (Reuters) - Ascelia Pharma AB:

* UPDATED SPARKLE TIMELINES DUE TO COVID-19 IMPACT

* COVID-19 PANDEMIC IS IMPACTING PACE OF PATIENT INCLUSION-RATE IN SPARKLE STUDY

* ASCELIA PHARMA - COMPLETION AND TOP LINE RESULTS OF PIVOTAL PHASE 3 STUDY SPARKLE WITH LEAD COMPOUND MANGORAL NOW EXPECTED IN H2 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below